Table. 1.

Retrospective series reporting minimal graft sizes for living donor liver transplantation

Study Region Definition SFSG Non-SFSG Portal flow modulation SFSS (%) Short-term survival Long-term survival
Kiuchi et al. (1999) [8] Japan GRWR <0.8% 21 255 - - 58% at 1 yr -
Nishizaki et al. (2001) [9] Japan GW/ESLV ≤30% 5 28 Portocaval shunt - 100% at median FU of 15 mo -
Ikegami et al. (2009) [10] Japan GV/SLV <35% 33 87 Splenic artery ligation/splenectomy 0 80.7% at 1 yr 64.2% at 5 yr
Moon et al. (2010) [11] South Korea GRWR <0.8% 35 392 - 5.7 87.8% at 1 yr 74.1% at 5 yr
Lee et al. (2014) [12] South Korea GRWR <0.7% 23 294 No 8 100% at 1 yr 91.7% at 3 yr
Au et al. (2015) [13] Hong Kong GW/ESLV ≤35% 21 212 Splenic artery ligation/portocaval shunt - - 81.0% at 5 yr
Ikegami et al. (2016) [14] Japan GV/SLV <35% 88 119 Splenectomy 11.4 - 91.4% at 5 yr
Liu et al. (2016) [15] China GRWR <0.7% 26 220 Splenic artery ligation/splenectomy 11 85.0% at 1 yr 73.2% at 5 yr
Wong et al. (2021) [16] Hong Kong GRWR <0.6% 39 506 Splenic artery ligation/splenectomy 12.8 0% hospital mortality 85.4% at 5 yr

SFSG, small-for-size graft; SFSS, small-for-size syndrome; GRWR, graft-recipient weight ratio; GW/ESLV, graft weight/estimated standard liver volume; GV/SLV, graft volume/standard liver volume.

Korean J Transplant 2022;36:165~172 https://doi.org/10.4285/kjt.22.0023
© Korean J Transplant